Is BMY Stock Worth Buying for the Dividend?

Подробнее о видео

One of the stocks that is talked about lot about lately is Bristol Myers Squibb.

And it has been an interesting ride this year with a lot of ups and downs resulting in a minus 7% year to date.

And the company announced pretty solid earnings were they beat the analyst estimations with quite some margin and the stock tanked about 11% after these earnings.

And we all know why most people like BMY stock, it’s the juicy 4.9% dividend yield. But what about that payout ratio? Is this a dividend yield trap or is this number diluting?

Let’s find out by diving in the earnings.

What does BMY do?
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development.

In this video:
00:00 - BMY Stock
00:44 - BMY Earnings
03:14 - BMY Fundamentals
06:47 - BMY Dividends
08:15 - BMY Returns
09:32 - BMY Price target
11:00 - Conclusion

Discord channel:

If you have some feedback for me or the video, please let me know!

Please LIKE, COMMENT, and SUBSCRIBE for more!

DISCLAIMER:
Remember to always do your own research and never fully trust on what I, or other Youtubers, say about a stock. I'm not a financial advisor and this content is just for entertaining purposes only.

Screenshots are taken within the Everythingmoney software, please check out there channel, their software is the best!

Hashtags:
#BMY #bristolmeyerssquib #dividendstock #dividends #dividend #dividendincome #dividendstrategy #dividendportfolio #dividendgrowth #dividendinvesting #dividendgrowth